METACARE amends capital increase for Techlabs acquisition
메타케어
118000
Signal Score
Historical Avg Return (5d)
+0.28%
Data Coverage
100%n=2398
Risk-adjusted indicator based on 2398 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEUTRAL
Key Numbers
- • Techlabs 100% common stock valuation: 163.8 billion KRW
- • Techlabs per share value: 54,991 KRW
- • Capital increase for other corporate securities acquisition: 6 billion KRW
AI Analysis Summary
METACARE Co., Ltd. has amended its paid-in capital increase report, clarifying the use of funds. The 6 billion KRW raised will be used to acquire shares in Techlabs Co., Ltd. to strengthen control and consolidate it as a subsidiary. A valuation report estimated Techlabs' 100% common stock at 163.8 billion KRW, with a per-share value of 54,991 KRW. The amendment provides clarity on the acquisition target, which could be seen as a strategic move, but the impact on existing shareholders from the dilution and the specific terms of the capital increase (e.g., number of new shares, issuance price) are not fully detailed in this amendment, leading to a neutral short-term outlook.
Track Korean Market Signals — Free
Sign up free to access live disclosures, AI analysis, and event filters.
Public Beta · No credit card required
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.